Welcome : Guest

Siegfried Holding AG (Switzerland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Siegfried Holding AG, which is principally involved in providing Customized Solutions for Services in the Development and Production of Active Pharmaceuticals. Illustrated with 89 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-08233
Price: $3500
Company Type: Public
Pages: 95
Date: November 2016
Market Data Tables: 89

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Siegfried Holding AG’s Sales by Product Segment Worldwide (2014-2015) in Percentage for Drug Substances, and Drug Products......7
Table 2: Siegfried Holding AG’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for USA, Switzerland, Europe, and Other Regions......8
Active Pharmaceutical Ingredients (API)......9
Table 3: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......9
Table 4: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......10
Table 5: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......11
Table 6: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......12
Table 7: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......13
Clinical Research Organizations......14
Table 8: Clinical Research Organization (CRO)'s Revenue by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for US, and Others......14
Clinical Trials......15
Table 9: Clinical Trials by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......15
Table 10: Clinical Trials Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value for Cardiovascular, Central Nervous Systems, Infectious Diseases, Oncology, and Others......16
Table 11: Gene Therapy Clinical Trials Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Phase I, n=1183, Phase I/II, n=384, Phase II, n=330, Phase II/III, n=20 and Phase III, n=74......17
Contract Research Organizations......18
Table 12: Contract Development and Manufacturing Organisation (CDMO) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for China, Europe, India, US, and Rest of World......18
Table 13: Contract Research Organisation (CRO) Market by Phase Type Worldwide (2015) - Percentage Share Breakdown by Value for Central Labs, Phase-I, Phase-II, Phase-III, Phase-IV, Preclinical, and Others......19
Table 14: Contract Research Organization Services Market by Segment in China (2015) - Percentage Breakdown by Value for Phase I, Phase IIIb-IV, Phase II-III, Pre-clinical and Other Services......20
Pharma R&D......21
Table 15: Pharma R&D Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for In-house and Outsourced to Contract Research Organization......21
Drugs......22
Table 16: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......22
Oral Solids......23
Table 17: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......23
Pulmonary Arterial Hypertension (PAH) Drugs......24
Table 18: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......24
Table 19: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......25
Table 20: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......26
Table 21: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......27
Table 22: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......28
Table 23: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......29
Table 24: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......30
Table 25: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......31
Table 26: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......32
Table 27: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......33
Depression Drugs......34
Table 28: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......34
Chronic Myelogenous Leukemia (CML) Market......35
Table 29: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......35
Glaucoma Drugs......36
Table 30: Glaucoma Drugs Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonists (AA), Beta Blocker Fixed Combos (BB-FC), Beta Blockers (BB), Carboic Anhydrase Inhibitors (CAI) and Prostaglandins (PGA)......36
Table 31: Glaucoma Disease Market for Prostaglandin Analogs (PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Latanoprost, Lumigan, Travatan and Others......37
Table 32: Glaucoma Disease Market for Non Prostaglandin Analogs (Non-PGAs) by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blockers (alone), Beta Blockers (combo), Canbone Anymore and Others......38
Table 33: Glaucoma Market by Product in the US (2015) - Percentage Share Breakdown by Value for Alpha Agonist, Beta Blocker, Beta Blocker Fixed Combo, Bimatoprost (Lumigan), Carbonic Anhydrase Inhibitor, Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......39
Ophthalmic Drugs......40
Table 34: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......40
Table 35: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......41
Asthma Drugs......42
Table 36: Asthma Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, North America and Rest of the World......42
Table 37: No. of Asthma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Europe, North America, and Rest of World......43
Table 38: Asthma Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Advair Diskus, Combivent, Proair HFA, Singulair, Spiriva HandiHaler, Symbicort, and Others......44
Diabetes Market......45
Table 39: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......45
Table 40: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-Like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......46
Table 41: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......47
Table 42: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......48
Table 43: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......49
Table 44: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......50
Table 45: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......51
Table 46: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......52
Table 47: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......53
Table 48: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......54
Diabetes Drugs......55
Table 49: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......55
Table 50: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......56
Table 51: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......57
Table 52: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......58
Table 53: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......59
Table 54: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......60
Table 55: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......61
Table 56: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......62
Table 57: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......63
Table 58: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......64
Table 59: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......65
Non-Insulin Anti-Diabetic Drugs......66
Table 60: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......66
Diabetic Macular Edema (DME)......67
Table 61: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......67
Table 62: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......68
Anti-Psychotics......69
Table 63: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......69
Table 64: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......70
Table 65: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......71
Clinical Research Organizations......72
Table 66: Market Shares of Leading Clinical Research Organization (CRO) Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Charles River Laboratories International, Inc., Covance, Inc., ICON Plc, INC Research, Inventiv Health, Inc., Laboratory Corporation of America Holdings, PAREXEL International, Pharmaceutical Product Development LLC, PRA International, Quest Diagnostics, Inc., Quintiles Transnational Holdings, Inc., Wuxi Pharmatech (Cayman) Inc., and Others......72
Clinical Trials......73
Table 67: Market Shares of Leading Phase I-IV Clinical Development Services Providers Worldwide (2015) - Percentage Share Breakdown by Value for ICON plc, PAREXEL, Pharmaceutical Product Development (PPD), Quintiles, Inc. and Others......73
Table 68: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......74
Contract Research Organizations......75
Table 69: Market Shares of Leading Bio-Contract Manufacturing Organization (CMO) Operations Worldwide (2015) - Percentage Breakdown by Volume for C.H. Boehringer Sohn AG & Co. KG, Celltrion, Lonza Group, Samsung Biologics, and Others......75
Table 70: Market Shares of Leading Contract Research Organization (CRO) Clinical Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Pharmaceutical Product Development LLC, PAREXEL International Corporation, Q-Trials and Others......76
Table 71: Market Shares of Leading Contract Research Organizers in China (2015) - Percentage Breakdown by Value for ShangPharma Corporation, Wuxi Pharmatech (Cayman), Inc. and Others......77
Contract Service Organizations (CSO)......78
Table 72: Market Shares of Leading Contract Service Organizations (CSO) by Value Sales in Australia (2014) - Percentage Breakdown for Australian Pharmaceutical Industries (API), Sigma Pharmaceuticals Limited (SIP), and Symbion Pharmacy Services......78
Ophthalmology Drugs......79
Table 73: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......79
Table 74: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......80
Diabetes Drugs......81
Table 75: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......81
Table 76: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......82
Table 77: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......83
Sitagliptin/Metformin......84
Table 78: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......84
Table 79: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......85
Table 80: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......86
Table 81: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......87
Metformin......88
Table 82: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......88
Antipsychotics......89
Table 83: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......89
Table 84: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......90
Table 85: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......91
Table 86: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......92
Latanoprost......93
Table 87: Prostaglandin Analogue Market by Product in the US (2015) - Percentage Share Breakdown by Value for Bimatoprost (Lumigan), Latanoprost (Xalatan, Generics), Travoprost (Travatan), and Others......93
Table 88: Siegfried Holding AG’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for USA, Switzerland and Others......94
Table 89: Siegfried Holding AG’s Sales by Business Segment Worldwide (2013-2014) in Percentage for Drug Substances and Drug Products......95